Author

A. Mehra

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Organism:C. elegans· 1 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Assay:imaging· 1 Approach:microscopy & imaging analysis· 1

Frequent Co-Authors

R. Tamayo· 2 shared A. D. Baik· 1 shared A. J. Murphy· 1 shared A. N. Economides· 1 shared A. O. Mujica· 1 shared A. Shen· 1 shared A. Singh· 1 shared B. B. Aldridge· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

R. Tamayo

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Unique growth and morphology properties of Clade 5 Clostridioides difficile strains revealed by single-cell time-lapse microscopy

J. W. Ribis, C. A. Nieto-Acuna, N. DiBenedetto, A. Mehra, Q. Dong, I. L. Nagawa, I. El Meouche, B. B. Aldridge, M. J. Dunlop, R. Tamayo, A. Singh, A. Shen

This study identifies distinct growth and chaining properties in Clade 5 Clostridioides difficile strains using time-lapse microscopy, linked to the cmr switch sequence orientation.

bioRxiv · Feb 13, 2024Microbiology

Multiple regulatory mechanisms control the production of CmrRST, an atypical signal transduction system in Clostridioides difficile

E. M. Garrett, A. Mehra, O. Sekulovic, R. Tamayo

This study identifies multiple regulatory mechanisms controlling cmrRST expression in C. difficile, including phase variation, c-di-GMP signaling, and autoregulation by CmrR.

bioRxiv · Oct 6, 2021Microbiology

Targeted delivery of acid alpha-glucosidase corrects skeletal muscle phenotypes in Pompe disease mice

A. D. Baik, P. T. Calafati, N. A. Aaron, A. Mehra, S. Moller-Tank, L. Miloscio, L. Wang, M. Praggastis, M. S. Birnbaum, C. Pan, S. Brydges, A. O. Mujica, P. Barbounis, N. W. Gale, N. Li, , K. D. Cygnar

This study demonstrates that targeted enzyme replacement therapy using antibody-enzyme fusion proteins improves skeletal muscle phenotypes in Pompe disease mice compared to standard enzyme replacement therapy.

bioRxiv · Apr 22, 2020 · PreprintBioengineering